The continuation of unfair trade practices in the pharma sector is due to the absence of effective national drug policy vis-a-vis pricing and quality standardisation of generic drugs. The vicious nexus of manufacturers, doctors, distributors and retailers has been fleecing every stratum of society with the myth of the efficacy of generic formulations and an eye only on the economic pie. To combat the nexus, the government should open more and more pan-India generic medicine centres and ensure non-erratic supply through its own manufacturing houses. Affordable medicine must be within the reach of all.
